← All FR Documents
Notice

Meeting of the Advisory Council for the Elimination of Tuberculosis

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, Centers for Disease Control and Prevention. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-19020
TypeNotice
PublishedSep 30, 2025
Effective Date-
RIN-
Docket ID-
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (699 words · ~4 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>Centers for Disease Control and Prevention</SUBAGY> <SUBJECT>Meeting of the Advisory Council for the Elimination of Tuberculosis</SUBJECT> <HD SOURCE="HED">AGENCY:</HD> Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). <HD SOURCE="HED">ACTION:</HD> Notice of meeting. <SUM> <HD SOURCE="HED">SUMMARY:</HD> In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Council for the Elimination of Tuberculosis (ACET). This meeting is open to the public, limited only by the number of audio and web conference lines (1,000 lines are available). Time will be available for public comment (registration is required to provide oral comment; see the Oral Public Comment section below). </SUM> <DATES> <HD SOURCE="HED">DATES:</HD> The meeting will be held on December 9-10, 2025, from 12 p.m. to 5 p.m., EST. Written comments must be submitted by December 2, 2025. Registration to make oral comments must also be submitted by December 2, 2025. </DATES> <HD SOURCE="HED">ADDRESSES:</HD> The public meeting will be held virtually through Microsoft Teams. Advanced registration is required to attend. Please register for each day of this meeting. For registration on December 9, 2025: <E T="03">https://events.gcc.teams.microsoft.com/event/bb9251cf-001e-4c99-93dd-8c04f4ac6313@9ce70869-60db-44fd-abe8-d2767077fc8f</E> . For registration on December 10, 2025: <E T="03">https://events.gcc.teams.microsoft.com/event/1011f44e-bf34-4095-a71a-db943d2599ef@9ce70869-60db-44fd-abe8-d2767077fc8f</E> . Registration for virtual attendance will remain open through the meeting. Prior to the meeting, each individual registrant will receive a registration confirmation along with an access link to the virtual meeting location. Written public comments and requests to make oral comments should be sent to <E T="03">nchhstppolicy@cdc.gov.</E> <FURINF> <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD> ACET Committee Management, Office of Policy, Planning, and Partnerships, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Email: <E T="03">nchhstppolicy@cdc.gov.</E> </FURINF> <SUPLINF> <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD> <E T="03">Purpose:</E> The Advisory Council for the Elimination of Tuberculosis is charged with providing advice and recommendations regarding the elimination of tuberculosis (TB) to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, Centers for Disease Control and Prevention (CDC). Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; provides guidance and review on CDC's Tuberculosis Prevention Research portfolio and program priorities; and reviews the extent to which progress has been made toward eliminating TB. <E T="03">Matters to be Considered:</E> The agenda will include discussions on: (1) CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention Update; (2) CDC's Division of Tuberculosis Elimination Update; (3) Tuberculosis Trials Consortium Update; (4) Reported Tuberculosis in the United States, 2024 (5) Patient Centered Experience and Care; and the (6) Biennial Letter Workgroup Update. Agenda items are subject to change as priorities dictate. <HD SOURCE="HD1">Public Participation</HD> <E T="03">Written Public Comment:</E> Members of the public are welcome to submit written comments in advance of the meeting. Written comments must be submitted by emailing <E T="03">nchhstppolicy@cdc.gov</E> with subject line “ACET December 2025 Written Public Comment Registration” by December 2, 2025. <E T="03">Oral Public Comment:</E> Individuals who would like to make an oral comment during the public comment period must register by emailing <E T="03">nchhstppolicy@cdc.gov</E> with subject line “ACET December 2025 Oral Public Comment Registration” by December 2, 2025. The public comment period is on December 10, 2025, at 2 p.m., EST. Comments are limited to no more than 5 minutes each. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by December 5, 2025 at 5 p.m. ET. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign <E T="04">Federal Register</E> notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. <SIG> <NAME>Kalwant Smagh,</NAME> Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. </SIG> </SUPLINF> <FRDOC>[FR Doc. 2025-19020 Filed 9-29-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.